SprintRay's Strategic Acquisition of EnvisionTEC's Portfolio
SprintRay, known as a pioneer in dental 3D printing, has made a significant move by acquiring the portfolio of dental products from EnvisionTEC. This includes their extensive catalog of patents and intellectual property focused on dental materials and advanced 3D printing technologies. The acquisition highlights SprintRay's continuing dedication to innovation and excellence within the field of dentistry.
Enhancing 3D Printing Capabilities
In entering this partnership with EnvisionTEC, SprintRay gains access to a wealth of knowledge and technology accumulated over more than two decades. EnvisionTEC has registered over 200 patents that cover various aspects of 3D printing hardware and materials tailored for dental applications. Their technology, notably the cDLM (continuous digital light manufacturing), enhances the efficiency and quality of dental product creation. This strategic acquisition is poised to not only bolster SprintRay's current offerings but also attract a broader customer base by integrating proven technologies into its existing framework.
Transforming Dental Practices
According to Amir Mansouri, PhD, SprintRay’s Co-founder and CEO, this acquisition is pivotal for ensuring that existing customers have continued access to essential tools and support. He emphasizes that the mission of transforming the landscape of dentistry through reliable and accessible 3D printing technologies is stronger than ever. This move is set to extend SprintRay's influence across both chairside and lab environments, broadening operational efficacy for dental professionals.
Key Initiatives Post-Acquisition
Several foundational initiatives will follow the integration of EnvisionTEC's dental portfolio:
- Dedicated Customer Support: Providing ongoing technical assistance to EnvisionTEC/Desktop Health customers to maintain smooth operations.
- Reliable Resin Supply: Ensuring continuous production of established EnvisionTEC and Desktop Health materials, including the highly-regarded Flexcera, to facilitate uninterrupted workflows.
- Cross-Platform Validation: SprintRay will conduct validation of select resins from EnvisionTEC/Desktop Health on its platforms, assessing compatibility with its own resins.
- Driving Dental Lab Innovation: With EnvisionTEC's lab-centric technologies amplifying SprintRay's offerings, the company is in a prime position to lead new innovations and establish elevated standards in dental lab 3D printing.
About SprintRay
SprintRay is dedicated to propelling dentistry into the future with innovative and user-friendly solutions. Its extensive range of products includes cutting-edge 3D printers, advanced post-processing systems, AI-assisted design software, and unique materials designed to enhance chairside productivity and improve lab functionality. With a consistent focus on innovation and reliable clinical outcomes, SprintRay aims to redefine patient care accessibility.
Frequently Asked Questions
What did SprintRay acquire from EnvisionTEC?
SprintRay acquired EnvisionTEC's dental product portfolio, including patents, trademarks, and technologies related to dental materials and 3D printing.
Why is this acquisition important for SprintRay?
The acquisition enhances SprintRay's commitment to dentistry and strengthens its product offerings, ensuring better support for dental professionals.
How will the acquisition affect existing EnvisionTEC customers?
Existing customers will receive continuous support and assurance of resin supply, maintaining their workflow without disruption.
What technologies are included in the acquisition?
The acquisition includes access to technologies like cDLM and various FDA-cleared materials like Flexcera, enhancing SprintRay’s capabilities.
What is SprintRay's focus moving forward?
SprintRay aims to continue transforming dentistry through innovative 3D printing solutions, improving accessibility and reliability for dental practices.
